These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 220970)

  • 1. Improved methods using HVJ(Sendai virus) for introducing substances into cells.
    Uchida T; Miyake Y; Yamaizumi M; Mekada E; Okada Y
    Biochem Biophys Res Commun; 1979 Mar; 87(2):371-9. PubMed ID: 220970
    [No Abstract]   [Full Text] [Related]  

  • 2. Reassembled HVJ (Sendai virus) envelopes containing non-toxic mutant proteins of diphtheria toxin show toxicity to mouse L cell.
    Uchida T; Yamaizumi M; Okada Y
    Nature; 1977 Apr; 266(5605):839-40. PubMed ID: 194160
    [No Abstract]   [Full Text] [Related]  

  • 3. Macromolecules can penetrate the host cell membrane during the early period of incubation with HVJ (Sendai virus).
    Yamaizumi M; Uchida T; Okada Y
    Virology; 1979 May; 95(1):218-21. PubMed ID: 220792
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity to mouse L cell shown by reassembled HVJ (Sendai virus) envelopes containing nontoxic mutant proteins of diphtheria toxin [proceedings].
    Uchida T; Yamaizumi M; Okada Y
    Jpn J Med Sci Biol; 1978 Apr; 31(2):213-4. PubMed ID: 210306
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of cytochalasin D on fusion of cells by HVJ (Sendai virus).
    Miyake Y; Kim J; Okada Y
    Exp Cell Res; 1978 Oct; 116(1):167-78. PubMed ID: 212281
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconstitution of lipid vesicles associated with HVJ (Sendai virus) sikes. Purification and some properties of vesicles containing nontoxic fragment A of diphtheria toxin.
    Uchida T; Kim J; Yamaizumi M; Miyake Y; Okada Y
    J Cell Biol; 1979 Jan; 80(1):10-20. PubMed ID: 217880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ.
    Miura N; Uchida T; Okada Y
    Exp Cell Res; 1982 Oct; 141(2):409-20. PubMed ID: 6291960
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of cell membranes with viral envelopes during fusion cells with HVJ (Sendai virus). II. Effects of pretreatment with a small number of HVJ.
    Okada Y; Hashimoto T; Maeda Y
    Exp Cell Res; 1975 Jul; 93(2):379-87. PubMed ID: 169134
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of cell membranes with viral envelopes during fusion of cells with HVJ (Sendai virus). III. Effects of mono- and di-saccharides on cell fusion and membrane movement of fused cells.
    Maeda Y; Kim J; Koseki I; Mekada E; Shiokawa Y; Okada Y
    Exp Cell Res; 1977 Aug; 108(1):95-106. PubMed ID: 196874
    [No Abstract]   [Full Text] [Related]  

  • 10. Fusion of Madin-Darby canine kidney cells by HVJ (Sendai virus): absence of direct association of virus particles with the site of membrane fusion.
    Kim J; Adachi T; Yoneda Y; Okada Y
    Eur J Cell Biol; 1990 Feb; 51(1):128-34. PubMed ID: 2158447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of fluorescently labeled Sendai virus envelopes with living cultured cells as monitored by fluorescence dequenching.
    Chejanovsky N; Henis YI; Loyter A
    Exp Cell Res; 1986 Jun; 164(2):353-65. PubMed ID: 3011469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of membrane fusion. II. Fusion of human erythrocytes by Sendai virus.
    Knutton S
    J Cell Sci; 1977 Dec; 28():189-210. PubMed ID: 202607
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus).
    Nakanishi M; Uchida T; Sugawa H; Ishiura M; Okada Y
    Exp Cell Res; 1985 Aug; 159(2):399-409. PubMed ID: 2993007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the study of Sendai virus hemolysis. I. Complete Sendai virus lacking in hemolytic activity.
    Homma M; Shimizu K; Shimizu YK; Ishida N
    Virology; 1976 May; 71(1):41-7. PubMed ID: 58472
    [No Abstract]   [Full Text] [Related]  

  • 15. Restitution of hemagglutinating activity to spikeless particles of HVJ (Sendai virus) by glycoprotein components of Newcastle disease virus.
    Iinuma M; Maeno K; Matsumoto T; Hoshino M
    Microbiol Immunol; 1977; 21(7):379-89. PubMed ID: 198639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Sendai virus and KB cell lines with altered cell fusion ability: a study employing electron spin resonance.
    Koyama AH; Maeda T; Toyama S; Ohnishi S; Uetake H; Toyama S
    Biochim Biophys Acta; 1978 Mar; 508(1):130-6. PubMed ID: 204348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of cell membranes with viral envelopes during fusion of cells with HVJ (Sendai virus).
    Okada Y; Koseki I; Kim J; Maeda Y; Hashimoto T
    Exp Cell Res; 1975 Jul; 93(2):368-78. PubMed ID: 169133
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy.
    Mizuguchi H; Nakanishi M; Nakanishi T; Nakagawa T; Nakagawa S; Mayumi T
    Br J Cancer; 1996 Feb; 73(4):472-6. PubMed ID: 8595161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane receptor mobility changes by Sendai virus.
    Maeda T; Eldridge C; Toyama S; Ohnishi SI; Elson EL; Webb WW
    Exp Cell Res; 1979 Oct; 123(2):333-43. PubMed ID: 227703
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of reconstituted Sendai virus envelopes for fusion-mediated microinjection of double-stranded RNA: inhibition of protein synthesis in interferon-treated cells.
    Arad G; Hershkovitz M; Panet A; Loyter A
    Biochim Biophys Acta; 1986 Jul; 859(1):88-94. PubMed ID: 2424506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.